<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00440219</url>
  </required_header>
  <id_info>
    <org_study_id>07-0001-A</org_study_id>
    <nct_id>NCT00440219</nct_id>
  </id_info>
  <brief_title>The Effect of Preoperative Oral Prednisone on the Operative Field During Nasal Polypectomy.</brief_title>
  <official_title>The Effect of Preoperative Oral Prednisone on the Operative Field During Nasal Polypectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samuel Lunenfeld Research Institute, Mount Sinai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samuel Lunenfeld Research Institute, Mount Sinai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine if a short course of oral prednisone helps to improve the
      operative field and ease of surgery by minimizing bleeding during nasal polypectomy surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be conducted as a double blinded randomized control trial and aims to recruit
      about 34 patients (17 patients per arm). Patients will be randomized to receive either
      prednisone 50 mg po x10 days or an identical looking placebo x10 days. Photographs of the
      polyps will be taken prior to the intervention, on the day of surgery and in the follow-up
      visit. Symptom survey (SNOT22) will also be administered at these same time points. Blood
      loss will be determined volumetrically from the suction canister and by using the Wormald
      Surgical field grading scale. Surgeons will also complete a survey postoperatively evaluating
      visibility, difficulty and ease of surgery. At 2 weeks, 1 month, 3 months and 6 months,
      patients will again fill out the Sino-nasal Outcome Test - 22 (SNOT-22) and the surgeon will
      do an endoscopic assessment by using the Peri-Operative Sinus Endoscopy (POSE) scoring system
      .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative blood loss. Wormald Surgical Field Grading Scale</measure>
    <time_frame>Intraoperative</time_frame>
    <description>This is an 11-point validated scale designed to provide a standardized method of documenting bleeding in endoscopic sinus surgery [Athanasiadis et al., 2007]. In addition blood loss during the surgery will be calculated from the suction canisters after accounting for the amount of irrigation used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visibility and easy of surgery</measure>
    <time_frame>Immediate Postoperative period</time_frame>
    <description>The surgeon will assess visibility and easy of surgery during the surgery and the technical difficulty of the surgery using two visual analogue scale questions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endoscopic assessment</measure>
    <time_frame>4 weeks, 3 months, 6 months</time_frame>
    <description>The Peri-Operative Sinus Endoscopy (POSE) scoring system (total score) will be used to assess the condition of the patients' sinus cavities and the Lindholdt scale will be used to provide objective measures of polyp recurrence size based on the percent obstruction of the nasal cavity and obstruction based on anatomic location.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life survey (SNOT22)</measure>
    <time_frame>2 weeks, 4 weeks, 3 months, 6 months post-op</time_frame>
    <description>The Sino-nasal Outcome Test - 22 (SNOT-22) will be used as the main instrument to assess patients' disease specific symptoms. The total score from the SNOT-22 at 3 months follow-up will be the main outcome. The profile of symptom scores over the full follow-up period will be a secondary outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Nasal Polyps</condition>
  <arm_group>
    <arm_group_label>Prednisone group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prednisone 50 mg daily for 10 days immediately pre-op</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo pill for 10 days immediately pre-operative</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral Prednisone</intervention_name>
    <description>Prednisone 50 mg once daily for 10 days pre-op</description>
    <arm_group_label>Prednisone group</arm_group_label>
    <other_name>steroids</other_name>
    <other_name>corticosteroids</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo comparator</intervention_name>
    <description>Placebo pill identical to Prednisone 10 days once daily pre-op</description>
    <arm_group_label>Placebo group</arm_group_label>
    <other_name>sugar pill</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with severe obstructing nasal polyps scheduled for surgery.

        Exclusion Criteria:

          -  Patient unable to tolerate side effects of prednisone

          -  Uncontrolled diabetes mellitus

          -  Hypertension

          -  Previous congestive heart failure

          -  Acute/chronic systemic infection

          -  History of hypersensitivity to prednisone

          -  History of cataracts or glaucoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ian Witterick, MD FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Toronto Department of Otolaryngology-Head and Neck Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Randy M Leung, BSc MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Toronto Department of Otolaryngology-Head and Neck Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai Hospital, University of Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Health Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6R 1B5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>O'Driscoll BR, Kalra S, Wilson M, Pickering CA, Carroll KB, Woodcock AA. Double-blind trial of steroid tapering in acute asthma. Lancet. 1993 Feb 6;341(8841):324-7.</citation>
    <PMID>8094111</PMID>
  </reference>
  <reference>
    <citation>Hissaria P, Smith W, Wormald PJ, Taylor J, Vadas M, Gillis D, Kette F. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006 Jul;118(1):128-33. Epub 2006 May 19.</citation>
    <PMID>16815148</PMID>
  </reference>
  <reference>
    <citation>Johansson L, Akerlund A, Holmberg K, Mel√©n I, Stierna P, Bende M. Evaluation of methods for endoscopic staging of nasal polyposis. Acta Otolaryngol. 2000 Jan;120(1):72-6.</citation>
    <PMID>10779190</PMID>
  </reference>
  <reference>
    <citation>Sieskiewicz A, Olszewska E, Rogowski M, Grycz E. Preoperative corticosteroid oral therapy and intraoperative bleeding during functional endoscopic sinus surgery in patients with severe nasal polyposis: a preliminary investigation. Ann Otol Rhinol Laryngol. 2006 Jul;115(7):490-4.</citation>
    <PMID>16900802</PMID>
  </reference>
  <reference>
    <citation>Athanasiadis T, Beule A, Embate J, Steinmeier E, Field J, Wormald PJ. Standardized video-endoscopy and surgical field grading scale for endoscopic sinus surgery: a multi-centre study. Laryngoscope. 2008 Feb;118(2):314-9.</citation>
    <PMID>17989575</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2007</study_first_submitted>
  <study_first_submitted_qc>February 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2007</study_first_posted>
  <last_update_submitted>January 8, 2014</last_update_submitted>
  <last_update_submitted_qc>January 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samuel Lunenfeld Research Institute, Mount Sinai Hospital</investigator_affiliation>
    <investigator_full_name>IWitterick</investigator_full_name>
    <investigator_title>Otolaryngologist Head-Neck Surgeon</investigator_title>
  </responsible_party>
  <keyword>Nasal polyps</keyword>
  <keyword>Steroids</keyword>
  <keyword>Prednisone</keyword>
  <keyword>Nasal polypectomy</keyword>
  <keyword>Blood loss, surgical</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nasal Polyps</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

